MGRX vs TXT · rev $456.0K vs P/E 19, rev $7.52B
Mangoceuticals, Inc. Common Stock (MGRX) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
MGRX currently screens at market cap $16.3M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the MGRX and TXT stock pages for the full models.
Not investment advice.